Masaru Iwasaki
Chuo, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 44 publications
Correction: A hybrid combination of in vitro cultured buccal mucosal cells using two different methodologies, complementing each other in successfully repairing a stricture-inflicted human male urethral epithelium.
Journal: Frontiers in urology
Published: February 18, 2026
A hybrid combination of in vitro cultured buccal mucosal cells using two different methodologies, complementing each other in successfully repairing a stricture-inflicted human male urethral epithelium.
Journal: Frontiers in urology
Published: October 08, 2025
4-Phenylbutyric Acid Improves Gait Ability of UBAP1-Related Spastic Paraplegia Mouse Model: Therapeutic Potential for SPG80.
Journal: International journal of molecular sciences
Published: August 14, 2025
Enhanced expression of dystrophin, IGF-1, CD44 and MYH3 in plasma and skeletal muscles including diaphragm of mdx mice after oral administration of Neu REFIX beta 1,3-1,6 glucan.
Journal: Scientific reports
Published: December 04, 2024
Intradiscal treatment with recombinant human MMP-7 for patients with lumbar disc herniation: A sham-controlled multicenter, single-blind, dose-escalation, single-dose, phase I/IIa study.
Journal: Journal of orthopaedic science : official journal of the Japanese Orthopaedic Association
Published: November 11, 2024
Efficient Control of IL-6, CRP and Ferritin in COVID-19 Patients With Two Variants of Beta-1,3-1,6 Glucans in Combination: An Open-Label, Prospective, Randomised Clinical Trial.
Journal: Global advances in integrative medicine and health
Published: July 19, 2024
Effects of Nichi BRITE β-glucans as an onco-nutrition adjuvant in patients undergoing subtotal stomach-preserving pancreaticoduodenectomy (SSPPD) for pancreatic, bile duct and duodenal malignancies: A clinical study.
Journal: Nutrition (Burbank, Los Angeles County, Calif.)
Published: June 28, 2024
Randomised trial of Aureobasidium pullulans-produced beta 1,3-1,6-glucans in patients with Duchenne muscular dystrophy: favourable changes in gut microbiota and clinical outcomes indicating their potential in epigenetic manipulation.
Journal: BMJ nutrition, prevention & health
Published: September 09, 2023
Re-examination of therapeutic management of muscular dystrophies using a vascular smooth muscle-centered approach.
Journal: Journal of smooth muscle research = Nihon Heikatsukin Gakkai kikanshi
Published: September 06, 2023
Corrigendum to "Beneficial immune-modulatory effects of the N-163 strain of Aureobasidium pullulans-produced 1,3-1,6 Beta glucans in Duchenne muscular dystrophy: Results of an open-label, prospective, exploratory case-control clinical study" [IBRO Neurosci. Rep. 15 (2023), pp. 90-99].
Journal: IBRO neuroscience reports
Published: August 18, 2023
Resolution of fibrosis in mdx dystrophic mouse after oral consumption of N-163 strain of Aureobasidium pullulans produced β-glucan.
Journal: Scientific reports
Published: April 18, 2023
Beneficial immune-modulatory effects of the N-163 strain of Aureobasidium pullulans-produced 1,3-1,6 Beta glucans in Duchenne muscular dystrophy: Results of an open-label, prospective, exploratory case-control clinical study.
Journal: IBRO neuroscience reports
Published: March 03, 2023
Last Updated: 09/26/2026